Product Information
DOXEPIN 50 MG CAPSULE is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.1463 per EA under NDC 27241016910. Its NADAC has been published 279 times since Feb 24, 2021.
Strength
50 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241016910
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212624On Market Since
12/20/2019
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 50 MG CAPSULE has been published 279 times since Feb 24, 2021, and over the history we have for it it has declined 69.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1463 per EA |
|---|---|
| All-time high | $0.4964 (Jun 16, 2021) |
| All-time low | $0.1165 (Nov 20, 2024) |
| 52-week high | $0.1798 |
| 52-week low | $0.1441 |
| Median price | $0.2665 |
| Average price | $0.2674 |
| Largest weekly change | -37.5% (Nov 20, 2024) |
| Weeks tracked | 279 |
| Tracking since | Feb 24, 2021 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DOXEPIN 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 50 MG CAPSULE, manufactured by Ajanta Pharma USA Inc., is $0.1463 per EA (NDC 27241016910), effective Jun 24, 2026.
How has the price of DOXEPIN 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 50 MG CAPSULE has declined 69.7%. It has been tracked across 279 weekly CMS publications since Feb 24, 2021.
What are the highest and lowest recorded NADAC prices for DOXEPIN 50 MG CAPSULE?
Since Feb 24, 2021, the NADAC for DOXEPIN 50 MG CAPSULE has ranged from a low of $0.1165 (Nov 20, 2024) to a high of $0.4964 (Jun 16, 2021), with a median of $0.2665 per EA.
Are there cheaper alternatives to DOXEPIN 50 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as DOXEPIN 50 MG CAPSULE, but none are currently priced below it.
Who manufactures DOXEPIN 50 MG CAPSULE?
DOXEPIN 50 MG CAPSULE (NDC 27241016910) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification